IL6 and COVID-19: In the pathological study, it was shown that COVID-19 increased von Wildebrand factor (vWF) levels, increased platelet accumulation via IL-6-related pathways, and as a result of all, fatty liver cells, increased liver cell damage and increased ALT levels were observed.